Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Will an Upbeat Earnings Report From Finisar Corporation (FNSR) Buck This Negative Trend? – JDS Uniphase Corp (JDSU), Cisco Systems, Inc. (CSCO)

Page 1 of 2

When 2012 ended, there was a feel-good factor about optical networking stocks JDS Uniphase Corp (NASDAQ:JDSU) and Finisar Corporation (NASDAQ:FNSR), both of whom I had expected would perform well this year. An uptick in telecom spending was supposed to be the primary catalyst behind the performance of both these companies, and Uniphase proved that the recovery is for real with a stellar quarterly report in January.

Uniphase’s management sounded quite positive about the industry’s prospects over the conference call, and the company’s decent outlook for the ongoing quarter indicated that the recovery isn’t a hoax. Uniphase has gained close to 4% so far this year, which doesn’t seem too handsome but is still better than Finisar’s predicament.

Cisco Systems, Inc. (NASDAQ:CSCO)What’s wrong?

Finisar Corporation (NASDAQ:FNSR) is down almost 13% this year, primarily due to a downgrade by Jefferies which flipped its rating on the stock to underperform. According to Jefferies analyst James Kisner, the availability of silicon-photonics technology, which would enable a higher rate of data transfer and make optical components obsolete, would knock the sails out of Finisar’s business.

Intel Corporation (NASDAQ:INTC) and Cisco Systems, Inc. (NASDAQ:CSCO) are the pioneers of this technology. In January, Intel said that it is moving silicon photonics from the research and development phase to the open source phase. The chip giant says that this technology would help data centers generate better performance while cutting down on size and costs. This particular piece of news has probably thrown a wrench into the recovery of these two optical networkers as they have been on the slide ever since the concerns were raised.

However, as Needham analyst Alexander Henderson told Bloomberg, the deployment of the technology would affect just 6% of Finisar’s total business. Moreover, Kisner himself says that the timing of deployment, pricing, and adoption of the silicon photonics technology isn’t concrete yet. Hence, investors should consider adding to their Uniphase and Finisar long positions while they are experiencing weakness.

JDS Uniphase Corp (NASDAQ:JDSU) already gave us a glimpse of its potential in its last quarterly report. The company is expected to ride the build out of infrastructure for faster networks and data centers. Its cutting-edge products, such as the 4G LTE test solution, and upcoming solutions for data centers should help Uniphase post a better year.

What to expect for Finisar Corporation (NASDAQ:FNSR)

Coming to Finisar Corporation (NASDAQ:FNSR), the company will be releasing its third-quarter results on Mar. 7. Analysts expect earnings of $0.16 per share on revenue of $238.4 million, and it shouldn’t be difficult for Finisar to satisfy them since it had called for an identical outlook when it last reported results. However, since telecom spending is expected to be in recovery mode, the outlook would hold center stage.

Ever since AT&T Inc. (NYSE:T) announced that it would be increasing its capital spending to enhance its wireless and wireline broadband networks, there wasn’t much doubt that optical networking stocks would start forecasting better. AT&T’s endeavor to cast its LTE net to 300 million customers by the end of 2014 is quite aggressive, since it would cover 99% of its customer base in 22 states. It would be spending $14 billion on this initiative over three years for deploying faster networks with total spending expected to be around $22 billion every year till 2015.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!